S100A11 and colorectal carcinoma: Our results establish a five-gene exosome signature with excellent diagnostic performance (AUC=0.965) and reveal S100A11 as a master regulator of CRC proliferation, immune evasion, and chemoresistance, providing a mechanistic basis for the development of targeted therapies.